Navigation Links
Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
Date:12/2/2008

MALVERN, Pa., Dec. 2 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that Ortho-McNeil-Janssen Pharmaceuticals' Levaquin is the preferred quinolone antibiotic among more than half of all general medical-surgical hospitals in the United States. Quinolone antibiotics are used to treat lung, sinus, skin and urinary tract infections caused by numerous bacterial pathogens.

"Based on our October 2008 audit, intravenous Levaquin was stocked in more hospitals than both Bayer's intravenous Cipro and generic intravenous ciprofloxacin combined," stated Matthew W. Mahr, Pharm.D., M.B.A., analyst at AMR.

The newly released edition of the Quinolone Monthly Monitor (U.S.) also finds that over 70 percent of hospitals reported having a closed hospital formulary for antibiotics. Large hospitals were found to be most likely to have a closed formulary for antibiotics. These closed formularies create restrictions on what can be prescribed in the hospital making it more difficult for a prescriber to use that medication.

Why Pharmaceutical Companies Need this Information

The Quinolone Monthly Monitor (U.S.) enables pharmaceutical companies to monitor formulary, stocking and restriction status of selected quinolone antibiotics. This study also gives information about the Pharmacy and Therapeutics Committee's actions for quinolones, which drive formulary and restriction status for these products.

About The Quinolone Monthly Monitor (U.S.)

The Quinolone Monthly Monitor (U.S.) is the industry's most comprehensive market research study of the formulary status of quinolone antibiotics. This study has been conducted monthly since June 1992 by collecting data from 300 pharmacy directors from a group of demographically representative acute care hospitals within the country.

'/>"/>
SOURCE Arlington Medical Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
3. Preferred Care Gold Ranked Number One Medicare Advantage Health Plan Nationally In U.S. News & World Report/NCQA Americas Best Health Plans 2008 Listing
4. MVP Health Care and IncentOne Partner to Provide Member Incentives for MVP and Preferred Care WellStyle Extras Program
5. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
6. Suboxone Fast Passing Methadone As Preferred Method Of Treatment For Opiate Detox
7. Mylan Declares Quarterly Preferred Stock Dividend
8. NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
9. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
10. Part D Advisors, Inc. Signs On as a TPAA Preferred Partner
11. PD-Rx Completes Call for Preferred A Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...USNewswire/ -- The American Public Health Associat...ovisions in the health reform bill passed last nig... the House takes important steps toward universal ...nd moving our health system from one that focuses ...g people healthy," said Georges C. Benjamin, MD, F...
(Date:11/8/2009)...ail Nation,s Job Creators ,, WASHINGTON, Nov. 8...use passage of the health care bill (H.R. 3962), S...Council) president & CEO Karen Kerrigan issued... those voting for H.R. 3962 voted to burden our na... taxes and penalties. Even in the best of economic...
(Date:11/8/2009)... of biopharmaceuticals to be available at the Comp... Toronto, ON (PRWEB) November ...erapure Biopharma Inc. today announced that the Co...rmaceutical grade freeze dryer and expects to make...vailable for contract manufacturing of biopharmace...
(Date:11/8/2009)...anic health advocates committed to achieving meani..., Nov. 7 "Tonight the U...d the voice of America,s families by passing the A...ate must deliver, without delay, on the promise of...Delgado, President and CEO of the National Allianc...
(Date:11/8/2009)...alth Care Reform Bill ,, Critical legislation...ll Americans ,, CHICAGO, Nov. 7 /PRNewswire-US...resentatives passed by a vote of 220-215, critical...hen Medicare for seniors and end discrimination by...cans out of affordable health coverage. ,, Th...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3
...ve exercise and diet led to significant, clinicall...al function among older long-term cancer survivors... to ENhancE Wellness) trial, according to Wendy De...the seventh annual American Association for Cancer...
...dulthood, the number of patients with Alzheimer,s ...the next several decades. , A team of national r... a rapid screening test to detect mild cognitive i...udy shows that the combination of a very brief thr...
...ance Fund,today announced it will extend credit to... business disruption caused by the fires in Montec...re than 900 residences and structures have been lo...rated in densely populated areas, we,understand th...
... with top,honors at the 2008 Medical Marketing and...rcial for Sarna(R), an over-the-counter line of lo...nsumer Health Division of Stiefel Laboratories. , ...eating,out four other finalists. , "We are e...
...that they do not want to ever become pregnant ofte... for hysteroscopic sterilization need to understan...pid recovery and return to daily activities, also ...hat the patient is not at risk for pregnancy. In a...
...ve,developmental diagnostic assay produced by Micr...n to be highly accurate for rapid detection,of ser...s assessment of,antibiotic susceptibility. The re... In the first presentation, MicroPhage scientists ...
Other Medicine News:Health News:Home-based diet and exercise intervention improves elderly cancer survivors' physical function 2Health News:New approach to screen individuals for early Alzheimer's disease 2Health News:Adair Greene-McCann Wins Gold with 'Relief' 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 2Health News:New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections 3
(Date:11/6/2009)...RNewswire/ -- Trius Therapeutics, Inc. announced t... Form S-1 with the U.S. Securities and Exchange Co...ic offering of shares of its common stock. All sha... will be offered by the Company. ,, Credit Suis...ning manager, Piper Jaffray & Co. is acting as...
(Date:11/6/2009)...ewswire-FirstCall/ -- Caraco Pharmaceutical Labora...olac tromethamine ophthalmic solution, 0.5% follow...inistration (FDA) for Sun Pharma,s Abbreviated New...ophthalmic solution on the first day following pat...apeutically equivalent to Acular® Ophthalmic ...
(Date:11/6/2009)...RNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: N...ing products for minimally disruptive surgical tre...ment of Michael J. Lambert as Executive Vice Presi...er 9, 2009. The Company also announced several ot...ael will be an excellent complement to the NuVasiv...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider 55276 1Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider 55276 2Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider 55276 3HealthWarehouse com Inc Announces Second Quarter Financial Results 3B Revenues Increase Significantly Over Second Quarter 2008 55274 1HealthWarehouse com Inc Announces Second Quarter Financial Results 3B Revenues Increase Significantly Over Second Quarter 2008 55274 2HealthWarehouse com Inc Announces Second Quarter Financial Results 3B Revenues Increase Significantly Over Second Quarter 2008 55274 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 1Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 4
...Bacillus coagulans significantly reduces abdominal...ew study published in the March issue of Postgrad...cteria, Bacillus coagulans GBI-30, PTA-6086 was ... in subjects with irritable bowel syndrome ( IBS...suffer from IBS, a condition characterized by a nu...
...--Study will evaluate proof of concept for company...or symptoms without side effects associated with h...Radius Health ("Radius") announced today that the ...f-of-concept Phase 2a study of RAD1901, an investi...RM) undergoing clinical evaluation for treatment o...
Other Medicine Technology:New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 2New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 3New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms 4Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 2Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes 3
...lipore has developed a range of Milli-Q ultrapure ...lity requirements. Each of the five new Milli-Q sy...nts detrimental to particular applications such as...ncorporate a high precision resistivity monitor th...
Vortex Genie 2 (220V)
Vortex Genie 2
Vortex adapter, for Labnet vortex, holds 4 each 15 ml tubes
Medicine Products: